Fairness opinions › Acquirers
JLL Partners: healthcare acquisitions with fairness opinions
2 public-company targets, 2011-2013, $3.0B combined enterprise value. The multiples JLL Partners paid and the banker analyses behind each target board's recommendation.
Deals
2
Median EV / EBITDA paid
10.4x
Median EV / revenue paid
1.81x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2013-11-18 | Patheon | JLL Partners | Pharmaceutical Services | $2.6B | 12.7x | 2.27x | 9.0%–11.0% | RBC Capital Markets, Jefferies |
| 2011-11-07 | American Dental Partners | JLL Partners | Professional Services | $398M | 8.1x | 1.36x | 11.5%–13.5% | Greenhill, BofA Securities |